These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10988241)

  • 1. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
    Lee GH; Badorff C; Knowlton KU
    Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
    Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
    Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
    Badorff C; Knowlton KU
    Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
    Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
    J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
    Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
    Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.
    Straub V; Duclos F; Venzke DP; Lee JC; Cutshall S; Leveille CJ; Campbell KP
    Am J Pathol; 1998 Nov; 153(5):1623-30. PubMed ID: 9811355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
    Badorff C; Lee GH; Knowlton KU
    Herz; 2000 May; 25(3):227-32. PubMed ID: 10904843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.
    Song KS; Scherer PE; Tang Z; Okamoto T; Li S; Chafel M; Chu C; Kohtz DS; Lisanti MP
    J Biol Chem; 1996 Jun; 271(25):15160-5. PubMed ID: 8663016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic loss of sarcolemmal dystrophin and spectrin: correlation with myocardial injury.
    Armstrong SC; Latham CA; Shivell CL; Ganote CE
    J Mol Cell Cardiol; 2001 Jun; 33(6):1165-79. PubMed ID: 11444921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters.
    Ikeda Y; Martone M; Gu Y; Hoshijima M; Thor A; Oh SS; Peterson KL; Ross J
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1362-70. PubMed ID: 10749734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
    Xiong D; Yajima T; Lim BK; Stenbit A; Dublin A; Dalton ND; Summers-Torres D; Molkentin JD; Duplain H; Wessely R; Chen J; Knowlton KU
    Circulation; 2007 Jan; 115(1):94-102. PubMed ID: 17190866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between dystrophin and the sarcolemma membrane.
    Chamberlain JS; Corrado K; Rafael JA; Cox GA; Hauser M; Lumeng C
    Soc Gen Physiol Ser; 1997; 52():19-29. PubMed ID: 9210217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel scheme of dystrophin disruption for the progression of advanced heart failure.
    Kawada T; Masui F; Tezuka A; Ebisawa T; Kumagai H; Nakazawa M; Toyo-Oka T
    Biochim Biophys Acta; 2005 Aug; 1751(1):73-81. PubMed ID: 16054019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.
    Barnabei MS; Sjaastad FV; Townsend D; Bedada FB; Metzger JM
    Sci Transl Med; 2015 Jul; 7(294):294ra106. PubMed ID: 26136477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease.
    Xiong D; Lee GH; Badorff C; Dorner A; Lee S; Wolf P; Knowlton KU
    Nat Med; 2002 Aug; 8(8):872-7. PubMed ID: 12118246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CVB infection and mechanisms of viral cardiomyopathy.
    Knowlton KU
    Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury.
    Campos EC; Romano MM; Prado CM; Rossi MA
    Int J Exp Pathol; 2008 Oct; 89(5):367-81. PubMed ID: 18808529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of western immunoblot for evaluation of myocardial dystrophin, alpha-sarcoglycan, and beta-dystroglycan in dogs with idiopathic dilated cardiomyopathy.
    Spier AW; Meurs KM; Coovert DD; Lehmkuhl LB; O'Grady MR; Freeman LM; Burghes AH; Towbin JA
    Am J Vet Res; 2001 Jan; 62(1):67-71. PubMed ID: 11197563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.
    Nishtala K; Phong TQ; Steil L; Sauter M; Salazar MG; Kandolf R; Kroemer HK; Felix SB; Völker U; Klingel K; Hammer E
    Proteomics; 2011 Nov; 11(22):4310-20. PubMed ID: 21954127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.